Quantum Biopharma (QNTM) Price to FCF (2020 - 2026)

Quantum Biopharma has disclosed Price to FCF across 7 years of filings, most recently posting 30.35 for Q2 2026.

• In Q2 2026, Price to FCF rose 33.83% year-over-year to 30.35; the TTM figure through Jun 2026 stood at 74.79 (up 32.62% YoY), while the FY2025 annual figure was 10.9, up 51.34% from the prior year.
• Price to FCF came in at 30.35 for Q2 2026 at Quantum Biopharma, down from 14.52 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 385.09 in Q1 2022 to a low of 820.82 in Q1 2023.
• Average Price to FCF over 5 years is 106.79, with a median of 29.7 recorded in 2025.
• Year-over-year, Price to FCF slumped 352.5% in 2023 and surged 341.93% in 2026.
• Over 5 years, Price to FCF stood at 39.23 in 2022, then slumped by 352.5% to 177.51 in 2023, then surged by 128.44% to 50.49 in 2024, then slumped by 157.56% to 29.06 in 2025, then fell by 4.41% to 30.35 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 30.35 in Q2 2026, 14.52 in Q1 2026, and 29.06 in Q3 2025.